Affiliation:
1. University of Kragujevac, Faculty of Medical Sciences, Kragujevac
Abstract
Introduction. Systemic sclerosis is a rare autoimmune disorder of the
connective tissue, gastrointestinal tract, lungs, kidneys, and
musculoskeletal tissue. It predominantly affects women. The localized
variant is limited scleroderma. Case Report. We present a 64-year-old female
patient with the diagnosis of limited scleroderma that has lasted for
thirteen years. She had hyperpigmentation, telangiectasias, and progressive
skin tightening of the face and fingers. Her blood test was positive for
antinuclear antibodies. Sclerodactyly began in the distal phalanx. Tender
and painful calcium deposits appeared subcutaneously on the surface of palms
and knees, radiographically confirmed. The patient was treated with surgical
debridement, vasodilating agents, corticosteroids, diltiazem, sildenafil,
nitro paste, antiplatelet drugs, and physical therapy. Conclusion. It is
necessary to control numerous factors that affect daily functioning,
including nutrition, pain therapy, musculoskeletal dysfunctions, and
emotional and social aspects caused by deformities. Targeted therapy in the
early stages of the disease, before irreversible damage occurs, improves the
overall quality of life.
Publisher
National Library of Serbia
Reference13 articles.
1. Hunzelmann N. Current treatment of systemic scleroderma. Hautarzt. 2018;69(11):901-7.
2. Coentro JQ, Pugliese E, Hanley G, Raghunath M, Zeugolis DI. Current and upcoming therapies to modulate skin scarring and fibrosis. Adv Drug Deliv Rev. 2019;146:37-59.
3. Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015;27(6):542-8.
4. Adigun R, Goyal A, Hariz A. Systemic sclerosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan [updated 2022 May 8; cited 2023 Jan 15]. Available from: https://ww.ncbi.nlm.nih.gov/books/NBK430875//
5. Allanore Y, Bozzi S, Terlinden A, Huscher D, Amand C, Soubrane C, et al. Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. Arthritis Res Ther. 2020;22(1):257.